United States — Food and Drug Administration & Kessler Topaz Meltzer & Check
6 shared events · Importance 3 · Last updated Aug 23, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to ImmunityBio regarding misleading efficacy claims made by Patrick Soon-Shiong about Anktiva, which triggered the stock price drop and subsequent lawsuits.
Kessler Topaz Meltzer & Check: Kessler Topaz Meltzer & Check has filed a securities fraud class action lawsuit against ImmunityBio and is encouraging investors to seek lead plaintiff status.
Apr 02, 2026 · 132 articles
Regulatory
United States — Food and Drug Administration: The FDA issued a warning letter to Medline citing significant manufacturing violations, which triggered the stock drop and subsequent investigations, reinforcing its regulatory role.
Kessler Topaz Meltzer & Check: Kessler Topaz Meltzer & Check is investigating potential securities law violations by Medline on behalf of investors, potentially leading to a class action lawsuit.
Jul 15, 2026 · 21 articles
Regulatory
United States — Food and Drug Administration: Regulator whose briefing documents and advisory committee vote triggered the stock collapse and legal actions.
Kessler Topaz Meltzer & Check: Law firm that announced the filing of a securities fraud class action lawsuit.
Jul 27, 2026 · 293 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Kessler Topaz Meltzer & Check interact across events, view sentiment trends, and discover connected entities.
Open Dashboard